| answer text |
<p>The Department's National Institute for Health Research (NIHR) is not currently
funding any Crohn’s vaccine development work at King’s College London.</p><p>The Government
has funding mechanisms in place for research and development relating to innovative
medicines.</p><p>The NIHR welcomes funding applications for research into any aspect
of human health, including Crohn’s disease and vaccines. These applications are subject
to peer review and judged in open competition, with awards being made on the basis
of the importance of the topic to patients and health and care services, value for
money and scientific quality.</p><p>The NIHR manages the Efficacy and Mechanism Evaluation
programme, which bridges the gap between preclinical studies and evidence of clinical
efficacy. The aim is to secure the progress of new technologies and interventions
through their early clinical trials and onto larger, later clinical trials. The programme
is funded by the Medical Research Council (MRC) and the NIHR.</p><p>Other sources
of funding include the Biomedical Catalyst, which is a funding programme jointly operated
by the MRC and Innovate UK. The programme provides responsive and effective support
for the best translational life science opportunities arising. Grants are available
to United Kingdom academics and small and medium enterprises seeking to move their
research more quickly from discovery to commercialisation.</p><p> </p>
|
|
